Description
Tauroursodeoxycholic Acid (TUDCA) – 500 mg
Tauroursodeoxycholic Acid is a bile acid–based supplement commonly used to support liver health and function. It is often utilized in settings involving liver stress or dysfunction, as it may help protect liver cells from damage caused by toxins, medications, or other metabolic stressors. At a 500 mg dosage, it is typically used to promote healthier bile flow and overall hepatic function.
How it works
Tauroursodeoxycholic Acid works by stabilizing liver cell membranes and improving bile acid circulation. This helps reduce cellular stress, inflammation, and the buildup of harmful substances within the liver. It also has antioxidant-like properties that may protect liver cells from oxidative damage. In addition, by supporting bile flow, it can assist in the digestion and absorption of dietary fats.
Proper Use and Dosage
The commonly used dosage of Tauroursodeoxycholic Acid is around 500 mg daily, often taken with food to improve absorption. Some users split the dose into morning and evening intake for more consistent support throughout the day. In certain cases, dosages may be adjusted depending on individual needs, but intake is generally kept within a moderate range, and exceeding high amounts is usually avoided without supervision.
Benefits
Tauroursodeoxycholic Acid is associated with improved liver function, protection against toxin-related liver stress, and enhanced bile flow. It is often discussed in relation to conditions such as fatty liver, cholestasis, and other bile-related digestive issues. It may also help reduce discomfort related to poor bile circulation, including digestive irregularities and reflux symptoms.
Side Effects
Most side effects are mild and primarily involve the digestive system. These may include bloating, loose stools, or mild gastrointestinal discomfort, especially during initial use. These effects often decrease as the body adapts. In rare cases, users may experience headaches or changes in bowel habits.


Reviews
There are no reviews yet.